Health News Roundup: US FDA approves GSK's bone marrow cancer therapy; Climate change hitting fight against AIDS, TB and malaria and more

15 story has been corrected show that momelotinib is approved for patients regardless of prior myelofibrosis therapy, not just for patients previously treated with JAK inhibitors, in paragraph 3) British drugmaker GSK Plc said on Friday the U.S. Food and Drug Administration had approved its oral therapy to treat anemia in patients with a type of bone marrow cancer called myelofibrosis. Climate change hitting fight against AIDS, TB and malaria Climate change and conflict are hitting efforts to tackle three of the world's deadliest infectious diseases, the head of the Global Fund to Fight AIDS, Tuberculosis and Malaria has warned.

Following is a summary of current health news briefs.

US FDA approves GSK's bone marrow cancer therapy

(This Sept. 15 story has been corrected show that momelotinib is approved for patients regardless of prior myelofibrosis therapy, not just for patients previously treated with JAK inhibitors, in paragraph 3) British drugmaker GSK Plc said on Friday the U.S. Food and Drug Administration had approved its oral therapy to treat anemia in patients with a type of bone marrow cancer called myelofibrosis.

Climate change hitting fight against AIDS, TB and malaria

Climate change and conflict are hitting efforts to tackle three of the world's deadliest infectious diseases, the head of the Global Fund to Fight AIDS, Tuberculosis and Malaria has warned. International initiatives to fight the diseases have largely recovered after being badly affected by the COVID-19 pandemic, according to the Fund’s 2023 results report released on Monday.

WHO chief pushes China for ‘full access’ to determine COVID’s origins - FT

The chief of the World Health Organization urged Beijing to offer more information on the origins of COVID-19 and is ready to send a second team to probe the matter, the Financial Times reported on Sunday. "We're pressing China to give full access, and we are asking countries to raise it during their bilateral meetings — to urge Beijing to co-operate," WHO Director-General Tedros Adhanom Ghebreyesus told the newspaper.

(With inputs from agencies.)